AdaptHealth Corp. 8-K/A

What Happened

• AdaptHealth Corp. filed Amendment No. 1 to its Form 8-K to correct the reported date of Daniel McFadden’s appointment as Chief Operating Officer (effective May 4, 2026) and to disclose additional compensation details that were not included in the original filing. The Compensation Committee approved the new pay and award on May 27, 2026.

Key Details

• Base salary increased from $410,000 to $550,000, effective retroactively to the May 4, 2026 appointment date.
• Annual incentive bonus target remains 100% of base salary; 2026 bonus target and any payout will be prorated based on actual 2026 base pay.
• One-time restricted stock unit (RSU) grant valued at $464,110 (per the company’s usual valuation):
  • 50% of the RSUs vest in equal annual installments over three years.
  • 50% are performance-based (0%–200% vesting) tied to AdaptHealth’s total shareholder return (TSR) vs. peers over a three-year performance period beginning February 1, 2026.
• All vesting is subject to Mr. McFadden’s continued employment.

Why It Matters

• This filing clarifies the official appointment date and provides concrete pay and equity terms for the company’s new COO, giving investors clearer insight into management costs and long-term incentives. The sizeable raise and performance-linked RSUs align McFadden’s compensation with company performance, which can affect future dilution and executive expense reporting.